(Q54439080)

29 May 2018

title

PPARgamma-dependent regulation of human macrophages in phagocytosis of apoptotic cells. (English)

1 reference

29 May 2018

1 reference

1 reference

1 reference

Gyöngyike Majai

1

1 reference

29 May 2018

Zsolt Sarang

2

1 reference

29 May 2018

Krisztián Csomós

3

1 reference

29 May 2018

Gábor Zahuczky

4

1 reference

29 May 2018

László Fésüs

5

1 reference

29 May 2018

language of work or name

English

0 references

publication date

1 May 2007

1 reference

29 May 2018

European Journal of Immunology

published in

1 reference

29 May 2018

volume

37

1 reference

29 May 2018

issue

5

1 reference

29 May 2018

page(s)

1343-1354

1 reference

29 May 2018

Innate immune discrimination of apoptotic cells: repression of proinflammatory macrophage transcription is coupled directly to specific recognition

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636398

Glucocorticoid augmentation of macrophage capacity for phagocytosis of apoptotic cells is associated with reduced p130Cas expression, loss of paxillin/pyk2 phosphorylation, and high levels of active Rac.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636398

Analysis of a tissue-specific enhancer: ARF6 regulates adipogenic gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636398

Differential regulation of chemokine gene expression by 15-deoxy-delta 12,14 prostaglandin J2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636398

Activation of peroxisome proliferator-activated receptor gamma does not inhibit IL-6 or TNF-alpha responses of macrophages to lipopolysaccharide in vitro or in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636398

A blast from the past: clearance of apoptotic cells regulates immune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636398

7 January 2021

Apoptotic cell removal in development and tissue homeostasis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636398

7 January 2021

The macrophage and the apoptotic cell: an innate immune interaction viewed simplistically?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636398

7 January 2021

Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636398

7 January 2021

Inflammation and the apopto-phagocytic system

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636398

7 January 2021

Apoptosis disables CD31-mediated cell detachment from phagocytes promoting binding and engulfment

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636398

7 January 2021

Vitronectin receptor-mediated phagocytosis of cells undergoing apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636398

7 January 2021

Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636398

7 January 2021

CD14-dependent clearance of apoptotic cells by human macrophages: the role of phosphatidylserine.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636398

7 January 2021

Transglutaminase 2-/- mice reveal a phagocytosis-associated crosstalk between macrophages and apoptotic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636398

7 January 2021

Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636398

7 January 2021

Biochemical and functional characterization of the interaction between pentraxin 3 and C1q.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636398

7 January 2021

Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636398

7 January 2021

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636398

7 January 2021

The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636398

7 January 2021

Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636398

7 January 2021

Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636398

7 January 2021

A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636398

7 January 2021

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636398

7 January 2021

Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636398

7 January 2021

PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636398

7 January 2021

Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636398

7 January 2021

Retinoids potentiate peroxisome proliferator-activated receptor gamma action in differentiation, gene expression, and lipid metabolic processes in developing myeloid cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636398

7 January 2021

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636398

7 January 2021

Oxidized low density lipoprotein inhibits interleukin-12 production in lipopolysaccharide-activated mouse macrophages via direct interactions between peroxisome proliferator-activated receptor-gamma and nuclear factor-kappa B

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636398

7 January 2021

Peroxisome proliferator-activated receptor gamma-dependent repression of the inducible nitric oxide synthase gene

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636398

7 January 2021

Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636398

7 January 2021

T0070907, a selective ligand for peroxisome proliferator-activated receptor gamma, functions as an antagonist of biochemical and cellular activities

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636398

7 January 2021

CED-12/ELMO, a novel member of the CrkII/Dock180/Rac pathway, is required for phagocytosis and cell migration

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636398

7 January 2021

Evidence for a conserved role for CRKII and Rac in engulfment of apoptotic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636398

7 January 2021

Engulfment of Apoptotic Cells Is Negatively Regulated by Rho-mediated Signaling

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636398

7 January 2021

Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636398

7 January 2021

The ATP binding cassette transporter ABC1, is required for the engulfment of corpses generated by apoptotic cell death.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636398

7 January 2021

Immunosuppressive effects of apoptotic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636398

7 January 2021

The role of PPAR-gamma in macrophage differentiation and cholesterol uptake.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636398

7 January 2021

Phagocytosis of senescent neutrophils by human monocyte-derived macrophages and rabbit inflammatory macrophages

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636398

7 January 2021

PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636398

7 January 2021

PPARgamma controls CD1d expression by turning on retinoic acid synthesis in developing human dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636398

7 January 2021

The prototypic tissue pentraxin PTX3, in contrast to the short pentraxin serum amyloid P, inhibits phagocytosis of late apoptotic neutrophils by macrophages

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636398

7 January 2021

Antiinflammatory Roles of Peroxisome Proliferator–activated Receptor γ in Human Alveolar Macrophages

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636398

7 January 2021

PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636398

7 January 2021

15-Deoxy-delta(12,14)-prostaglandin J(2) inhibits IL-10 and IL-12 production by macrophages

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636398

7 January 2021

Activation of PPARalpha or gamma reduces secretion of matrix metalloproteinase 9 but not interleukin 8 from human monocytic THP-1 cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636398

7 January 2021

Interleukin-10-deficient mice develop chronic enterocolitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636398

7 January 2021

Involvement of IL-10 in peroxisome proliferator-activated receptor gamma-mediated anti-inflammatory response in asthma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636398

7 January 2021

Glucocorticoid-regulated transcription factors.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636398

7 January 2021

MIF regulates innate immune responses through modulation of Toll-like receptor 4

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636398

7 January 2021

Interferon gamma suppresses glucocorticoid augmentation of macrophage clearance of apoptotic cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636398

7 January 2021

PPAR gamma is required for placental, cardiac, and adipose tissue development

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636398

7 January 2021

Improved insulin-sensitivity in mice heterozygous for PPAR-gamma deficiency

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636398

7 January 2021

Muscle-specific Pparg deletion causes insulin resistance

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636398

7 January 2021

Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636398

7 January 2021

Conditional gene targeting in macrophages and granulocytes using LysMcre mice.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636398

7 January 2021

Identifiers

DOI

10.1002/EJI.200636398

1 reference

29 May 2018

PubMed ID

17407194

1 reference

29 May 2018